<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="0" ids="33838">nucleoside</z:chebi> analogs <z:chebi fb="0" ids="2038">5-azacytidine</z:chebi> (<z:chebi fb="0" ids="2038">azacitidine</z:chebi>) and <z:chebi fb="0" ids="50131">5-aza-2'-deoxycytidine</z:chebi> (<z:chebi fb="0" ids="50131">decitabine</z:chebi>) are active against <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Cellular transport across membranes is crucial for uptake of these highly polar hydrophilic molecules </plain></SENT>
<SENT sid="2" pm="."><plain>We assessed the ability of <z:chebi fb="0" ids="2038">azacitidine</z:chebi>, <z:chebi fb="0" ids="50131">decitabine</z:chebi>, and, for comparison, <z:chebi fb="0" ids="175901">gemcitabine</z:chebi>, to interact with human <z:chebi fb="0" ids="33838">nucleoside</z:chebi> transporters (hNTs) in Saccharomyces cerevisiae cells (hENT1/2, hCNT1/2/3) or Xenopus laevis oocytes (hENT3/4) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three drugs inhibited hCNT1/3 potently (K (i) values, 3-26 μM), hENT1/2 and hCNT2 weakly (K (i) values, 0.5-3.1 mM), and hENT3/4 poorly if at <z:hpo ids='HP_0000001'>all</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Rates of transport of [(3)H]<z:chebi fb="0" ids="175901">gemcitabine</z:chebi>, [(14)C]<z:chebi fb="0" ids="2038">azacitidine</z:chebi>, and [(3)H]<z:chebi fb="0" ids="50131">decitabine</z:chebi> observed in Xenopus oocytes expressing individual recombinant hNTs differed substantially </plain></SENT>
<SENT sid="5" pm="."><plain>Cytotoxicity of <z:chebi fb="0" ids="2038">azacitidine</z:chebi> and <z:chebi fb="0" ids="50131">decitabine</z:chebi> was assessed in hNT-expressing or hNT-deficient cultured human cell lines in the absence or presence of transport inhibitors where available </plain></SENT>
<SENT sid="6" pm="."><plain>The rank order of cytotoxic sensitivities (IC (50) values, μM) conferred by hNTs were hCNT1 (0.1) &gt; hENT1 (0.3) ≫ hCNT2 (8.3), hENT2 (9.0) for <z:chebi fb="0" ids="2038">azacitidine</z:chebi> and hENT1 (0.3) &gt; hCNT1 (0.8) ⋙ hENT2, hCNT2 (&gt;100) for <z:chebi fb="0" ids="50131">decitabine</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Protection against cytotoxicity was observed for both drugs in the presence of inhibitors of <z:chebi fb="0" ids="33838">nucleoside</z:chebi> transport, thus suggesting the importance of hNTs in manifestation of toxicity </plain></SENT>
<SENT sid="8" pm="."><plain>In summary, <z:hpo ids='HP_0000001'>all</z:hpo> seven hNTs transported <z:chebi fb="0" ids="2038">azacitidine</z:chebi>, with hCNT3 showing the highest rates, whereas hENT1 and hENT2 showed modest transport and hCNT1 and hCNT3 poor transport of <z:chebi fb="0" ids="50131">decitabine</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Our results show for the first time that <z:chebi fb="0" ids="2038">azacitidine</z:chebi> and <z:chebi fb="0" ids="50131">decitabine</z:chebi> exhibit different human <z:chebi fb="0" ids="33838">nucleoside</z:chebi> transportability profiles and their cytotoxicities are dependent on the presence of hNTs, which could serve as potential biomarkers of clinical response </plain></SENT>
</text></document>